Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
2.030
+0.040 (2.01%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Pyxis Oncology Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $8 | Buy | Reiterates | $8 | +294.09% | Oct 1, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $6 → $8 | Buy | Maintains | $6 → $8 | +294.09% | Sep 26, 2026 |
| William Blair | William Blair | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 9, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $12 → $19 | Buy | Reiterates | $12 → $19 | +835.96% | Sep 9, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $5 → $6 | Buy | Maintains | $5 → $6 | +195.57% | Sep 9, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $7 | Buy | Maintains | $7 | +244.83% | Aug 18, 2026 |
| Wedbush | Wedbush | Buy Reiterates $6 | Buy | Reiterates | $6 | +195.57% | Aug 14, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Maintains $7 | Buy | Maintains | $7 | +244.83% | Jun 30, 2026 |